Back
BioXcel Therapeutics Stock Price Chart
Sponsored
BTAI
Sponsored
Billionaire Investors Join Forces to Fund Next Generation
Learn More
Sell
25
BTAI
BioXcel Therapeutics
Last Price:
2.84
Seasonality Move:
37.68%
7 Day Trial
ALL ACCESS PASS
$
7
Biden's Oil War: The Administration Is All-In on Green Energy.
Download Free Report- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BTAI is experiencing slight buying pressure.
BioXcel Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.81 | Buy |
20-day SMA: | 2.91 | Sell |
50-day SMA: | 3.03 | Sell |
200-day SMA: | 5.21 | Sell |
8-day EMA: | 2.84 | Buy |
20-day EMA: | 2.9 | Sell |
50-day EMA: | 3.03 | Sell |
200-day EMA: | 6.27 | Sell |
BioXcel Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.07 | Sell |
Relative Strength Index (14 RSI): | 47.87 | Sell |
Chaikin Money Flow: | 58769 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.79 - 3.15) | Sell |
Bollinger Bands (100): | (2.65 - 3.95) | Sell |
BioXcel Therapeutics Technical Analysis
Mar 14 | Mar 15 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 22 | Mar 25 | Mar 26 | Mar 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for BioXcel Therapeutics Stock
Is BioXcel Therapeutics Stock a Buy?
- BioXcel Therapeutics share price is 2.88 while BTAI 8-day simple moving average is 2.81, which is a Buy signal.
- The stock price of BTAI is 2.88 while BioXcel Therapeutics 20-day SMA is 2.91, which makes it a Sell.
- BioXcel Therapeutics 50-day simple moving average is 3.03 while BTAI share price is 2.88, making it a Sell technically.
- BTAI stock price is 2.88 and BioXcel Therapeutics 200-day simple moving average is 5.21, creating a Sell signal.
BTAI Technical Analysis vs Fundamental Analysis
Sell
25
BioXcel Therapeutics (BTAI)
is a Sell
Is BioXcel Therapeutics a Buy or a Sell?
-
BioXcel Therapeutics stock is rated a Sell
The current BioXcel Therapeutics [BTAI] share price is $2.88. The Score for BTAI is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
BioXcel Therapeutics Stock Info
Market Cap:
88.06M
Price in USD:
2.88
Share Volume:
528.92K
BioXcel Therapeutics 52-Week Range
52-Week High:
29.56
52-Week Low:
1.91
Sell
25
BioXcel Therapeutics (BTAI)
is a Sell
BioXcel Therapeutics Share Price Forecast
-
What is the BioXcel Therapeutics stock price today?
The BioXcel Therapeutics stock price is 2.88 USD today. -
Will BTAI stock go up or go down?
BioXcel Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is BioXcel Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, BioXcel Therapeutics is overvalued.
Is BioXcel Therapeutics Stock a Buy?
- BioXcel Therapeutics share price is 2.88 while BTAI 8-day exponential moving average is 2.84, which is a Buy signal.
- The stock price of BTAI is 2.88 while BioXcel Therapeutics 20-day EMA is 2.90, which makes it a Sell.
- BioXcel Therapeutics 50-day exponential moving average is 3.03 while BTAI share price is 2.88, making it a Sell technically.
- BTAI stock price is 2.88 and BioXcel Therapeutics 200-day simple moving average is 6.27, creating a Sell signal.
Fundamental Analysis of BioXcel Therapeutics
Is BioXcel Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.80 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.60 per share, and an increase next year of $1.14 per share.
Technical Analysis of BioXcel Therapeutics
Should I short BioXcel Therapeutics stock?
- BTAI Moving Average Covergence Divergence (MACD) indicator is -0.07, suggesting BioXcel Therapeutics is a Sell
- BioXcel Therapeutics Relative Strength Index (RSI) is 47.87, which suggest BioXcel Therapeutics is oversold
- The Bollinger Bands (25) for BioXcel Therapeutics is (2.79 - 3.15), which suggest BioXcel Therapeutics is a Sell
- The Bollinger Bands (100) for BioXcel Therapeutics is (2.65 - 3.95), which suggest BioXcel Therapeutics is a Sell
* BioXcel Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.